P/E ratio for COSMOS Pharmaceutical (3349.T)
P/E ratio as of April 2024 (TTM): 22.6
According to COSMOS Pharmaceutical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 22.6088. At the end of 2022 the company had a P/E ratio of 22.8.
P/E ratio history for COSMOS Pharmaceutical from 2009 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 22.8 | -14% |
| 2021 | 26.5 | 3.13% |
| 2020 | 25.7 | 8.88% |
| 2019 | 23.6 | 22.34% |
| 2018 | 19.3 | -28.4% |
| 2017 | 26.9 | -5.52% |
| 2016 | 28.5 | -6.05% |
| 2015 | 30.3 | -4.25% |
| 2014 | 31.7 | 39.8% |
| 2013 | 22.6 | 17.83% |
| 2012 | 19.2 | 71.71% |
| 2011 | 11.2 | -13.92% |
| 2010 | 13.0 | 26.28% |
| 2009 | 10.3 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.